1.545
3.00%
0.045
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNS Giù?
Forum
Previsione
Frazionamento azionario
Marinus Pharmaceuticals Inc Borsa (MRNS) Ultime notizie
Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024 - BioSpace
Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024 - StockTitan
Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference - StockTitan
Marinus Pharmaceuticals (NASDAQ:MRNS) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Marinus Pharmaceuticals (NASDAQ:MRNS) Stock Rating Upgraded by StockNews.com - MarketBeat
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $12.75 Average PT from Analysts - MarketBeat
Marinus Pharmaceuticals Inc (MRNS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Marinus Pharmaceuticals Hosts Investor and Analyst Day - MyChesCo
Marinus Pharmaceuticals (NASDAQ:MRNS) Downgraded by StockNews.com to "Sell" - MarketBeat
Marinus Pharmaceuticals Reports Robust Q2 2024 Financial Results and Business Progress - MyChesCo
Cantor Fitzgerald Weighs in on Marinus Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:MRNS) - MarketBeat
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024 - StockTitan
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024 - Business Wire
LADENBURG THALM/SH SH Lowers Marinus Pharmaceuticals (NASDAQ:MRNS) to Neutral - Defense World
Marinus Pharmaceuticals (LTS:0JYL) Asset Turnover : 0.07 (As of Jun. 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Marinus Pharmaceuticals, Inc. Reduced by HC Wainwright (NASDAQ:MRNS) - MarketBeat
Leerink Partnrs Brokers Cut Earnings Estimates for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Marinus Pharmaceuticals, Inc. Expected to Post Q3 2024 Earnings of ($0.47) Per Share (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Simply Wall St
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Thinking about buying stock in Archer Aviation, Marinus Pharmace - GuruFocus.com
Marinus Pharmaceuticals, Inc. Forecasted to Earn FY2028 Earnings of $2.72 Per Share (NASDAQ:MRNS) - MarketBeat
Marinus Pharmaceuticals, Inc. Forecasted to Earn FY2028 Earnings of $2.72 Per Share (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Upgraded by StockNews.com to Hold - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Given "Buy" Rating at HC Wainwright - MarketBeat
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com
Global Maternal Mental Health Market to Exhibit Growth at Tremendous CAGR of ~15% by 2030 | DelveInsight - GlobeNewswire Inc.
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com Australia
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com Canada
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com India
Marinus Pharmaceuticals Inc (MRNS) Q2 2024 Earnings Call Transcr - GuruFocus.com
Company News for Aug 14, 2024 - MSN
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com UK
Company News for Aug 14, 2024 - Yahoo Finance
Marinus Pharmaceuticals (NASDAQ:MRNS) Cut to Neutral at LADENBURG THALM/SH SH - MarketBeat
Marinus Pharmaceuticals: Q2 Earnings Snapshot - Darien Times
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit - Longview News-Journal
Marinus Pharmaceuticals maintains Buy rating with $10 target By Investing.com - Investing.com Canada
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com Australia
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com Canada
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth - Investing.com India
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth - Investing.com
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com UK
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - citybiz
Marinus Pharmaceuticals: Q2 Earnings Snapshot - San Francisco Chronicle
Marinus Pharmaceuticals: Q2 Earnings Snapshot - The Washington Post
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Lelezard
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Canada Finance
Marinus Pharma falls after missing Q2 revenue estimates - XM
Marinus Pharmaceuticals: Q2 Earnings Snapshot - CTPost
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Winchester Herald Chronicle
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Business Wire
Even after rising 11% this past week, Marinus Pharmaceuticals (NASDAQ:MRNS) shareholders are still down 90% over the past three years - Simply Wall St
Vanguard Group Inc. Purchases 132,689 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (MRNS) to Release Quarterly Earnings on Tuesday - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $12.75 Consensus Target Price from Analysts - MarketBeat
Scott Braunstein Sells 12,145 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Stock - Defense World
Scott Braunstein Sells 12,145 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Stock - MarketBeat
A company insider recently sold 2,153 shares of Marinus Pharmaceuticals Inc [MRNS]. Should You also Consider to Sale? – Knox Daily - Knox Daily
There is no way Marinus Pharmaceuticals Inc (MRNS) can keep these numbers up - SETE News
Marinus Pharmaceuticals (MRNS) to Release Earnings on Tuesday - MarketBeat
Marinus Pharmaceuticals Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Closing Bell Recap: Marinus Pharmaceuticals Inc (MRNS) Ends at 1.10, Reflecting a -15.38 Downturn - The Dwinnex
Technical analysis of Marinus Pharmaceuticals Inc (MRNS) stock chart patterns - US Post News
3 Biotech Stocks to Sell in August Before They Crash & Burn - InvestorPlace
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):